Qube Research & Technologies Ltd

Position in CGEN — Compugen Ltd

CIK 1729829 LONDON, X0

Position in CGEN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$25,979

-$23,607 QoQ

Shares Held

12,197

-58.7% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,979	12,197	-58.7%	Shares	Sole	2026-05-15
2024-06-30	$49,586	29,516	-46.3%	Shares	Sole	2024-08-14
2024-03-31	$141,734	54,936	+17852.9%	Shares	Sole	2024-05-14
2023-12-31	$605	306	+188.7%	Shares	Sole	2024-02-13
2023-09-30	$98	106	-99.6%	Shares	Sole	2023-11-13
2022-03-31	$85,371	26,513	+79.2%	Shares	Sole	2022-05-09
2021-06-30	$122,494	14,794	+10.5%	Shares	Sole	2021-08-13
2020-12-31	$162,104	13,386	-69.5%	Shares	Sole	2021-02-16
2020-09-30	$713,878	43,931	+6.6%	Shares	Sole	2020-11-12
2020-06-30	$619,214	41,226	+211.1%	Shares	Sole	2020-08-14
2020-03-31	$96,202	13,251	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.